Phagenesis Selected for MedTech Innovator’s 2022 Cohort

MedTech Innovator Announces Top 50 Startups Selected for the 2022 Cohort in Tenth Year of World’s Largest MedTech Accelerator Program

2022 Cohort Includes Medical Device, Diagnostics and Digital Health Startups From Across the Globe Developing Innovative Technologies to Improve Patient Care and Outcomes

June 07, 2022 08:00 AM Eastern Daylight Time

LOS ANGELES–(BUSINESS WIRE)–MedTech Innovator, the world’s largest accelerator of medical technology companies, today announced the 50 companies selected to participate in the organization’s flagship four-month Accelerator program, featuring medical device, diagnostic, and digital health technologies from around the globe. As 2022 Cohort members, these startups will get unparalleled visibility and access to leading medtech manufacturers, providers, investors, and other industry stakeholders. At the conclusion of the program, MedTech Innovator will award $500,000 in cash and in-kind prizes in the final competition held at The MedTech Conference, powered by AdvaMed in Boston this fall.

Read more here.